Skip to main content
SpringerLink
Log in

Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status

  • Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

An Erratum to this article was published on 01 May 2014

Abstract

Pregnancy is becoming a relatively common event in patients with pituitary tumors (PT), due to the increasing availability of medical treatments, which control pituitary diseases associated with the development of PT. However, the presence of PT and its treatment may be a disturbing factor for pregnancy, and pregnancy significantly influences the course and the management of PT. This review summarizes the knowledge about the management of PT during pregnancy and the occurrence of pregnancy in patients with pre-existent PT, focusing on secreting PT characterized by hormonal excess and on clinically non-functioning PT often associated to hormone deficiency, which configure the hypopituitaric syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N, Randall RV (1990) The pituitary gland in pregnancy. A clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65:461–474

    Article  CAS  PubMed  Google Scholar 

  2. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) (2011) Williams textbook of endocrinology, 12th edn. Saunders Elsevier, Philadelphia

  3. Molitch ME (2003) Pituitary tumors and pregnancy. GH IGF Res 13:S38–S44

    CAS  Google Scholar 

  4. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613–619

    Article  PubMed  Google Scholar 

  5. Beckers A, Daly AF (2007) The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157(4):371–382

    Article  CAS  PubMed  Google Scholar 

  6. Moertini P, Losa M, Barzaghi R, Boari N, Giovanelli M (2005) Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56(6):1222–1233

    Article  Google Scholar 

  7. Hirshfeld-Cytron J, Kim HH (2006) Treatment of fertility in women with pituitary tumors. Expert Rev Anticancer Ther 6(9 Suppl):s55–s62

    Article  PubMed  Google Scholar 

  8. Chandrashekar V, Zaczek D, Bartke A (2004) The consequences of altered somatotropic system on reproduction. Biol Reprod 71(1):17–27

    Article  CAS  PubMed  Google Scholar 

  9. Levy J (1995) Endogenous plasma GH and the occurrence of pregnancies in patients undergoing in vitro fertilization and embryo transfer with ovarian stimulation. Human Reprod 10:1065–1069

    Google Scholar 

  10. Chrousos GP, Torpy DJ, Gold PW (1998) Interactions between the hypothalamic–pituitary–adrenal axis and the female reproductive system: clinical implications. Ann Int Med 129(3):229–240

    Article  CAS  PubMed  Google Scholar 

  11. Cooke PS, Holsberger DR, Witorsch RJ, Sylvester PW, Meredith JM, Treinen KA, Chapin RE (2004) Thyroid hormone, glucocorticoids, and prolactin at the nexus of physiology, reproduction, and toxicology. Toxicol Appl Pharmacol 194:309–335

    Article  CAS  PubMed  Google Scholar 

  12. Poppe K, Velkeniers B, Glinoer D (2007) Thyroid disease and female reproduction. Clin Endocrinol (Oxf) 66(3):309–321

    Article  CAS  Google Scholar 

  13. Dinc H, Esen F, Demirci A, Sari A, Resit Gumele H (1998) Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol 39:64–69

    CAS  PubMed  Google Scholar 

  14. Elster AD, Sanders TG, Vines FS, Chen MY (1991) Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 181:531–535

    CAS  PubMed  Google Scholar 

  15. Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ (1988) Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85:217–220

    Article  CAS  PubMed  Google Scholar 

  16. Waters MJ, Kaye PL (2002) The role of growth hormone in fetal development. Growth Hormon IGF Res 12:137–146

    Article  CAS  Google Scholar 

  17. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G (1988) The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 66:1171–1180

    Article  CAS  PubMed  Google Scholar 

  18. Eriksson L, Frankenne F, Eden S, Hennen G, Von Schoultz B (1989) Growth hormone 24-h serum profiles during pregnancy lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 106:949–953

    Article  Google Scholar 

  19. Beckers A, Stevenaert A, Foidart J-M, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71:725–731

    Article  CAS  PubMed  Google Scholar 

  20. Winter JSD (1998) Fetal and neonatal adrenocortical physiology. In: Polin RA, Fox WW (eds) Maternal–fetal endocrinology. WB Saunders, Philadelphia, pp 2447–2459

    Google Scholar 

  21. Liggins GC (1994) The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev 6:141–150

    Article  CAS  PubMed  Google Scholar 

  22. Pepe GJ, Albrecht ED (1990) Regulation of the primate fetal adrenal cortex. Endocr Rev 11:151–176

    Article  CAS  PubMed  Google Scholar 

  23. Mastorakos G, Ilias I (2003) Maternal and fetal hypothalamic–pituitary–adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 997:136–149

    Article  CAS  PubMed  Google Scholar 

  24. Lindsay JR, Nieman LK (2005) The hypothalamic–pituitary–adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26(6):775–799

    Article  CAS  PubMed  Google Scholar 

  25. Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK (2005) Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 90(5):3077–3083

    Article  CAS  PubMed  Google Scholar 

  26. Nolten WE, Lindheimer MD, Rueckert PA, Oparil S, Ehrlich EN (1980) Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 51:466–472

    Article  CAS  PubMed  Google Scholar 

  27. Fisher DA, Nelson JC, Carlton EI, Wilcox RB (2000) Maturation of human hypothalamic–pituitary–thyroid function and control. Thyroid 10:229–234

    Article  CAS  PubMed  Google Scholar 

  28. Vulsma T, Gons MH, de Vijlder JJ (1989) Maternal–fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 321:13–16

    Article  CAS  PubMed  Google Scholar 

  29. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J, Lejeune B (1990) Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71(2):276–287

    Article  CAS  PubMed  Google Scholar 

  30. Soldin OP (2006) Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals. Ther Drug Monit 28(1):8–11

    Article  PubMed Central  PubMed  Google Scholar 

  31. Kredentser JV, Hoskins CF, Scott JZ (1981) Hyperprolactinemia: a significant factor in female infertility. Am J Obstet Gynecol 139:264–267

    CAS  PubMed  Google Scholar 

  32. Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485–534

    Article  CAS  PubMed  Google Scholar 

  33. Molitch ME (1999) Diagnosis and treatment of prolactinomas. Adv Intern Med 44:117–153

    CAS  PubMed  Google Scholar 

  34. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF, The Cabergoline Comparative Study Group (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 331:904–909

    Article  CAS  PubMed  Google Scholar 

  35. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65(2):265–273

    Article  Google Scholar 

  36. Herman-Bonert V, Seliverstow M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83:727–731

    CAS  PubMed  Google Scholar 

  37. Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155(2):279–284

    Article  CAS  PubMed  Google Scholar 

  38. Grasso LFS, Pivonello R, Auriemma RS, Galdiero M, De Leo M, Cozzolino A, Vitale P, Simeoli C, Lombardi G, Colao A (2010) Acromegaly and women fertility. Minerva Endocrinol 35(4):13–26

    Google Scholar 

  39. Beuscher MA, McClamrock HD, Adashi EY (1992) Cushing’s syndrome in pregnancy. Obstet Gynecol 79:130–137

    Google Scholar 

  40. Benoit R, Pearson-Murphy BE, Robert F, Marcovitz S, Hardy J, Tsoukas G, Gardiner RJ (1980) Hyperthyroidism due to a pituitary TSH secreting tumour with amenorrhoea-galactorrhoea. Clin Endocrinol 12(1):11–19

    Article  CAS  Google Scholar 

  41. Kupersmith MJ, Rosenberg C, Kleinberg D (1994) Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121:473–477

    Article  CAS  PubMed  Google Scholar 

  42. Colao A, Lombardi G (1998) Growth-hormone and prolactin excess. Lancet 352:1455–1461

    Article  CAS  PubMed  Google Scholar 

  43. Colao A, Di Sarno A, Landi ML, Cirillo S, Sarnacchiaro F, Facciolli G, Pivonello R, Cataldi M, Merola B, Annunziato L, Lombardi G (1997) Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82:3574–3579

    Article  CAS  PubMed  Google Scholar 

  44. Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G (2000) Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab 85:2247–2252

    CAS  PubMed  Google Scholar 

  45. Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R, Di Somma C, Faggiano A, Lombardi G, Colao A (2001) Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab 86:5256–5261

    Article  PubMed  Google Scholar 

  46. Di Sarno A, Landi ML, Marzullo P, Di Somma C, Pivonello R, Cerbone G, Lombardi G, Colao A (2000) The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol 53:53–60

    Article  Google Scholar 

  47. Colao A, Lombardi G, Annunziato L (2000) Cabergoline. Expert Opin Pharmacother 1:555–574

    Article  CAS  PubMed  Google Scholar 

  48. Molitch ME (1985) Pregnancy and the hyperprolactinemic woman. N Engl J Med 312:1364–1370

    Article  CAS  PubMed  Google Scholar 

  49. Musolino NR, Bronstein MD (2001) Prolactinomas and pregnancy. In: Bronstein MD (ed) Pituitary tumors and pregnancy. Kluwer Academic Publishers, Norwell, pp 91–108

    Chapter  Google Scholar 

  50. Auriemma RS, Perone Y, Di Sarno A, Grasso LFS, Guerra E, Gasperi M, Pivonello R, Colao A (2013) Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 98:372–379

    Article  CAS  PubMed  Google Scholar 

  51. Krupp P, Monka C, Richter K (1988) The safety aspects of infertility treatments. In: Proceedings of the second world congress of gynecology and obstetrics, Rio de Janeiro, p 9

  52. Konopka P, Raymond JP, Merceron RE, Seneze J (1983) Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 146(8):935–938

    CAS  PubMed  Google Scholar 

  53. Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84:2518–2522

    Article  CAS  PubMed  Google Scholar 

  54. Colao A, Abs R, Bárcena DG, Chanson P, Paulus W, Kleinberg DL (2008) Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clin Endocrinol (Oxf) 68(1):66–71 Epub 2007 Aug 29

    Article  CAS  Google Scholar 

  55. Ricci E, Parazzini F, Motta T, Ferrari CI, Colao A, Clavenna A, Rocchi F, Gangi E, Paracchi S, Gasperi M, Lavezzari M, Nicolosi AE, Ferrero S, Landi ML, Beck-Peccoz P, Bonati M (2002) Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 16:791–793

    Article  CAS  PubMed  Google Scholar 

  56. Robert E, Musatti L, Piscitelli G, Ferrari CI (1996) Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 10:333–337

    Article  CAS  PubMed  Google Scholar 

  57. Molitch ME (2011) Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab 25(6):885–889

    Article  CAS  PubMed  Google Scholar 

  58. Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T (2010) Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 95(6):2672–2679

    Article  CAS  PubMed  Google Scholar 

  59. Lebbe M, Hubinont C, Bernard P, Maiter D (2010) Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol (Oxf) 73(2):236–242

    CAS  Google Scholar 

  60. Stalldecker G, Mallea-Gil MS, Guitelman M, Alfieri A, Ballarino MC, Boero L, Chervin A, Danilowicz K, Diez S, Fainstein-Day P, García-Basavilbaso N, Glerean M, Gollan V, Katz D, Loto MG, Manavela M, Rogozinski AS, Servidio M, Vitale NM (2010) Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature. Pituitary 13(4):345–350

    Article  CAS  PubMed  Google Scholar 

  61. De Mari M, Zenzola A, Lamberti P (2002) Antiparkinsonian treatment in pregnancy. Mov Disord 17:428–429

    Article  PubMed  Google Scholar 

  62. Acharya V (2004) Review of pregnancy reports in patients on pergolide treatment. Eli Lilly Co., Indianapolis

    Google Scholar 

  63. Webster J (1996) A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 14(4):228–238

    Article  CAS  PubMed  Google Scholar 

  64. Brodsky JB, Cohen EN, Brown BW Jr, Wu ML, Whitcher C (1980) Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 138:1165–1167

    CAS  PubMed  Google Scholar 

  65. Rossi AM, Vilska S, Heinonen PK (1995) Outcome of pregnancies in women with treated or untreated hyperprolactinemia. Eur J Obstet Gynecol Reprod Biol 63:143–146

    Article  CAS  PubMed  Google Scholar 

  66. Crosignani PG, Mattei AM, Scarduelli C, Cavioni V, Boracchi P (1989) Is pregnancy the best treatment for hyperprolactinemia? Hum Reprod 4(8):910–912

    CAS  PubMed  Google Scholar 

  67. Ikegami H, Aono T, Koizumi K, Koike K, Fukui H, Tanizawa O (1987) Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil Steril 47(5):867–869

    CAS  PubMed  Google Scholar 

  68. Molitch ME (2006) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 35:99–116

    Article  PubMed  Google Scholar 

  69. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152

    Article  CAS  PubMed  Google Scholar 

  70. Melmed S (1990) Acromegaly. N Engl J Med 322:966–977

    Article  CAS  PubMed  Google Scholar 

  71. van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long term treatment of acromegaly with pegvisomant, a growth hormone antagonist. Lancet 358:1754–1759

    Article  PubMed  Google Scholar 

  72. Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G (2006) Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol 154(3):467–477

    Article  CAS  PubMed  Google Scholar 

  73. Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114(3):135–139

    Article  CAS  PubMed  Google Scholar 

  74. Colao A, Ferone D, Marzullo P, Di Sarno A, Cerbone G, Sarnacchiaro F, Cirillo S, Merola B, Lombardi G (1997) Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 82:518–523

    Article  CAS  PubMed  Google Scholar 

  75. Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF, Seckl JE (2002) The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 57:401–404

    Article  CAS  Google Scholar 

  76. Boulanger C, Vezzosi D, Bennet A, Lorenzini F, Fauvel J, Caron P (2004) Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. J Endocrinol Invest 27(5):465–470

    Article  CAS  PubMed  Google Scholar 

  77. Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F (1996) Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J Clin Endocrinol Metab 81:1164–1168

    CAS  PubMed  Google Scholar 

  78. Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 92(9):3374–3377

    Article  CAS  PubMed  Google Scholar 

  79. Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A (2012) Pregnancy and acromegaly: a review. Pituitary 15:59–63

    Article  PubMed  Google Scholar 

  80. Maffei P, Tamagno G, Nardelli GB, Milan G, Martini C, DeCarlo E, Dassie F, Vettor R, Sicolo N (2010) Treatment with somatostatin analogs in acromegalic women during pregnancy. Minerva Endocrinol 35(4):49–69

    Google Scholar 

  81. Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95:4680–4687

    Article  CAS  PubMed  Google Scholar 

  82. Cheng S, Grasso LFS, Martinez-Orozco JA, Al-Agha R, Pivoenllo R, Colao A, Ezzat S (2012) Pregnancy in acromegaly: experience from two referral centers and systematic review of literature. Clin Endocrinol 76:264–271

    Article  Google Scholar 

  83. Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JAH, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16:294–302

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  84. Bevan JS, Gough MH, Gillmer MD, Burke CW (1987) Cushing’s syndrome in pregnancy: the timing of definitive treatment. Clin Endocrinol 27(2):225–233

    Article  CAS  Google Scholar 

  85. Aron DC, Schnall AM, Sheeler LR (1990) Cushing’s syndrome and pregnancy. Am J Obstet Gynecol 162:244–252

    Article  CAS  PubMed  Google Scholar 

  86. Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s syndrome. Endocrinol Metab Clin North Am 37(1):135–149

    Article  CAS  PubMed  Google Scholar 

  87. Chico A, Manzanares JM, Halperin I, Martonez de Osaba MJ, Adelantado J, Webb SM (1996) Cushing’s disease and pregnancy. Eur J Obstet Gynecol Reprod Biol 64:143–146

    Article  CAS  PubMed  Google Scholar 

  88. Guilhaume B, Sanson ML, Billaud L, Bertagna X, Laudat MH, Luton JP (1992) Cushing’s syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med 1(2):83–89

    CAS  PubMed  Google Scholar 

  89. Lekarev O, New MI (2011) Adrenal disease in pregnancy. Best Pract Res Clin Endocrinol Metab 25(6):959–973

    Article  CAS  PubMed  Google Scholar 

  90. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17(6):610–638

    CAS  PubMed  Google Scholar 

  91. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84(2):476–486

    Article  CAS  PubMed  Google Scholar 

  92. Chaiamnuay S, Moster M, Katz MR, Kim YN (2003) Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary 6(2):109–113

    Article  PubMed  Google Scholar 

  93. Murata Y, Ando H, Nagasaka T, Takahashi I, Saito K, Fukugaki H, Matsuzawa K, Mizutani S (2003) Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocrinol Metab 88(5):1988–1993

    Article  CAS  PubMed  Google Scholar 

  94. Sedgh G et al (2012) Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet. doi:10.1016/S0140-6736(11)61786-8

Download references

Conflict of interest

AC has been principal investigator of research studies from Novartis, Ipsen, Pfizer and Lilly, has received research grants from Ferring, Lilly, Ipsen, Merck-Serono, Novartis, Novo-Nordisk and Pfizer, has been occasional consultant for Novartis, Ipsen and Pfizer, and has received fees and honoraria from Ipsen, Novartis, and Pfizer. RP has been principal investigator of research studies from Novartis, has received research grants from Novartis, Pfizer, Viropharma and IBSA, has been occasional consultant for Novartis, Ipsen, Pfizer, Viropharma, Ferring, Italfarmaco and received fees and honoraria for presentations from Novartis. MCDM, RSA, CA, LFSG, AC, MDL, GDP, GL have nothing to disclose.

Author information

Authors and Affiliations

  1. Section of Endocrinology, Department of Clinical Medicine and Surgery, “Federico II” University, Naples, Italy

    Rosario Pivonello, Maria Cristina De Martino, Renata S. Auriemma, Ludovica F. S. Grasso, Alessia Cozzolino, Monica De Leo, Annamaria Colao & Gaetano Lombardi

  2. Section of Gynaecology, Department of Neurosciences, Reproductive and Odontostomatologic Sciences, “Federico II” University, Naples, Italy

    Carlo Alviggi & Giuseppe De Placido

  3. Department of Molecular and Clinical Endocrinology and Oncology , “Federico II” University, Via S. Pansini 5, 80131, Naples, Italy

    Rosario Pivonello

Authors
  1. Rosario Pivonello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Cristina De Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renata S. Auriemma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlo Alviggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ludovica F. S. Grasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessia Cozzolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Monica De Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giuseppe De Placido
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gaetano Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosario Pivonello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pivonello, R., De Martino, M.C., Auriemma, R.S. et al. Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. J Endocrinol Invest 37, 99–112 (2014). https://doi.org/10.1007/s40618-013-0019-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-013-0019-8

Keywords

Search

Navigation